Part III. Systemically administered taurine: pharmacologically activated mechanisms.
Miyamoto
Tadaomi A
TA
Research Department, Kokura Memorial Hospital, Kitakyushu City, Japan. almiyamo@f3.dion.ne.jp
Miyamoto
Koho J
KJ
Miyamoto
Masumi R
MR
D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D007328:Insulin / Q000378:metabolism; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D007511:Ischemia; D008297:Male; D010919:Placebos; D011817:Rabbits; D013654:Taurine / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D001786:Blood Glucose; D007328:Insulin; D010919:Placebos; D013654:Taurine; D005680:gamma-Aminobutyric Acid; D007334:Insulin-Like Growth Factor I